跳至主要内容
临床试验/JPRN-UMIN000003080
JPRN-UMIN000003080已完成未知

Double Blind Study for Effects of Donepezil Hydrochloride on Parkinson's Disease - EDP2010 study

Clinical Research Center, Utano National Hospital, National Hospital Organization0 个研究点目标入组 30 人开始时间: 2010年1月30日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Subjects taking anti-cholinergic drugs, including trihexyphenidyl, biperidien, profenamine, piroheptine, metixene, mazaticol, promethazine, cyproheptadine. 2) Subjects with diffuse Lewy body disease (according to third report of the DLB consortium) . 3) Present or previous diagnosis of schizophrenia. 4) Severe liver dysfunction or severe renal dysfuction. 5) Present or previous diagnosis of sick sinus syndrome 6) Present or previous diagnosis of broncheal asthma. 7) Subjects who investigators judge as inappropriate.

研究者

发起方
Clinical Research Center, Utano National Hospital, National Hospital Organization

相似试验